Key Highlights
- ARK Invest acquired 39,691 shares of Tesla valued at $14.3M distributed across three ETFs on April 6, 2026
- Tesla’s stock price declined more than 2% to $352.82 following disappointing Q1 delivery figures
- ARK divested 25,240 Teradyne shares valued at $7.8M, marking continued selling pressure
- Wedbush’s Dan Ives maintained his Buy recommendation with a $600 price objective for Tesla
- JPMorgan’s Ryan Brinkman retained a Sell rating with a $145 price target
Cathie Wood’s investment firm ARK Invest executed multiple transactions on Monday, April 6, 2026, increasing its Tesla holdings while reducing exposure to Teradyne, a semiconductor testing equipment manufacturer.
Tesla’s stock experienced a decline exceeding 2% during the trading session, settling at $352.82. The downturn followed the electric vehicle maker’s disappointing first-quarter delivery numbers.
Wood’s firm accumulated 39,691 Tesla shares spread across three exchange-traded funds: ARK Innovation, ARK Autonomous Technology & Robotics, and ARK Space Exploration & Innovation. The combined acquisition totaled approximately $14.3 million.
This purchase represents part of a broader strategy. ARK has been consistently expanding its Tesla holdings, capitalizing on recent price declines as a strategic entry point.
Conversely, ARK disposed of 25,240 shares of Teradyne valued at $7.8 million through its ARKK and ARKQ portfolios. This continues a pattern of sales initiated on March 30 and March 31, indicating a strategic withdrawal from the position.
Analyst Community Remains Divided on Tesla’s Prospects
Wood’s bullish stance on Tesla isn’t universally shared among market observers.
Dan Ives from Wedbush, recognized as a five-star analyst, reaffirmed his Buy recommendation and maintained his $600 price objective following the delivery announcement. While acknowledging the underwhelming results, Ives noted that subdued demand had been largely anticipated by the analyst community.
Contrasting sharply, JPMorgan’s Ryan Brinkman maintained his Sell rating alongside a $145 price target, characterizing Tesla’s performance as having “collapsed” across critical metrics.
The substantial disparity between these price projections—$145 compared to $600—illustrates the significant disagreement within the analyst community regarding Tesla’s trajectory.
Based on data from 32 analysts surveyed during the past three months, Tesla carries a consensus Hold rating. This comprises 13 Buy recommendations, 11 Hold ratings, and 8 Sell ratings.
The mean price target stands at $393.97, representing approximately 11.66% potential upside from Monday’s closing price.
Additional ARK Portfolio Adjustments on April 6
ARK simultaneously divested 29,773 shares of BWX Technologies for $6.4 million and 8,484 shares of Cameco valued at $955,043.
The investment firm also liquidated 92,758 shares of Strata Critical Medical, generating approximately $384,945. This selling activity has persisted since the previous week.
On the acquisition front, ARK purchased 4,394 shares of Kodiak AI through its ARKQ ETF, valued at $32,603. ARK has been steadily accumulating Kodiak AI shares beginning March 30.
Current Market Position
As of April 6, Tesla concluded trading at $352.82, with the analyst consensus price target of $393.97 indicating modest but favorable upside potential at present valuation levels.
